FDA.reportPublic FDA data

aliskiren 150 MG / valsartan 160 MG Oral Tablet

RxCUI
1011718
RxNorm name
aliskiren 150 MG / valsartan 160 MG Oral Tablet
Term type
SCD
Status
Active
Updated
2026-10-26 03:52:42

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aliskiren hemifumarate150 MG / 1 EACHaliskirenaliskiren
valsartan160 MG / 1 EACHvalsartanvalsartan

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aliskiren325646
valsartan69749

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRaliskiren 150 MG / valsartan 160 MG Oral Tablet1NAMES
RxNorm Namealiskiren 150 MG / valsartan 160 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
RxCUI10117181CODES
MMSL_CODECD256181CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC09DXAngiotensin II receptor blockers (ARBs), other combinationsATC1-4aliskiren / valsartan
ATCC09CAAngiotensin II receptor blockers (ARBs), plainATC1-4valsartan
ATCC09XARenin-inhibitorsATC1-4aliskiren
FDASPLN0000175561Angiotensin 2 Receptor BlockerEPChas_epcvalsartan
FDASPLN0000175900Renin InhibitorEPChas_epcaliskiren
FDASPLN0000000070Angiotensin 2 Receptor AntagonistsMOAhas_moavalsartan
FDASPLN0000175899Renin InhibitorsMOAhas_moaaliskiren
MEDRTD000577AmidesCHEMhas_ingredientaliskiren
MEDRTD005650FumaratesCHEMhas_ingredientaliskiren
MEDRTD013449SulfonamidesCHEMci_chemclassaliskiren
MEDRTD000068756ValsartanCHEMhas_ingredientvalsartan
MEDRTD001002AnuriaDISEASEci_withaliskiren
MEDRTD002675Child, PreschoolDISEASEci_withaliskiren
MEDRTD003920Diabetes MellitusDISEASEci_withaliskiren
MEDRTD003928Diabetic NephropathiesDISEASEmay_treatvalsartan
MEDRTD004342Drug HypersensitivityDISEASEci_withvalsartan
MEDRTD006333Heart FailureDISEASEmay_treatvalsartan
MEDRTD006929HyperaldosteronismDISEASEci_withvalsartan
MEDRTD006967HypersensitivityDISEASEci_withaliskiren
MEDRTD006973HypertensionDISEASEmay_treatvalsartan
MEDRTD006973HypertensionDISEASEmay_treataliskiren
MEDRTD007022HypotensionDISEASEci_withvalsartan
MEDRTD011247PregnancyDISEASEci_withvalsartan
MEDRTD018487Ventricular Dysfunction, LeftDISEASEmay_treatvalsartan
MEDRTN0000000070Angiotensin 2 Receptor AntagonistsMOAhas_moavalsartan
MEDRTN0000000181Angiotensin-converting Enzyme InhibitorsMOAci_moaaliskiren
MEDRTN0000000181Angiotensin-converting Enzyme InhibitorsMOAhas_moaaliskiren
MEDRTN0000175899Renin InhibitorsMOAhas_moaaliskiren
MEDRTN0000175899Renin InhibitorsMOAci_moaaliskiren
MEDRTN0000178477Decreased Blood PressurePEhas_pevalsartan
MEDRTN0000178477Decreased Blood PressurePEhas_pealiskiren
MEDRTN0000008669Decreased Intravascular VolumePEhas_pevalsartan
MEDRTN0000008731Decreased Mineralocorticoid SecretionPEhas_pevalsartan
MEDRTN0000008859Decreased Renal K+ ExcretionPEhas_pevalsartan
MEDRTN0000009553Increased Renal Na+ ExcretionPEhas_pevalsartan
MEDRTN0000009825Renal Arterial VasoconstrictionPEci_pevalsartan
MEDRTN0000009826Renal Arterial VasodilationPEhas_pevalsartan

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
CODESSNOMEDCT1208678000
CODESVUID4029398
CODESVUID4029399
NAMESPrescribable Synonymaliskiren 150 MG / valsartan 160 MG Oral Tablet
SOURCESSourceUS Edition of SNOMED_CT